Known targets — ChEMBL curated mechanism
rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Erythromycin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 2/20 | 0.86 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.86 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.81 |
| ▸ | SLCO1B3 | Q9NPD5 | 3/20 | 0.81 |
| ▸ | SLCO1B1 | Q9Y6L6 | 3/20 | 0.81 |
| ▸ | USP2 | O75604 | 3/20 | 0.81 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.81 |
| ▸ | MEN1 | O00255 | 1/20 | 0.81 |
| ▸ | TP53 | P04637 | 1/20 | 0.81 |
| ▸ | MAPT | P10636 | 1/20 | 0.81 |
| ▸ | HPGD | P15428 | 1/20 | 0.81 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.81 |
| ▸ | RECQL | P46063 | 1/20 | 0.81 |
| ▸ | BLM | P54132 | 1/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.81 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.81 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.80 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.80 |
| ▸ | MLNR | O43193 | 2/20 | 0.80 |
| ▸ | TSHR | P16473 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Erythromycin SCHEMBL7597003 | 0.92 | ABCB11 (1.00) | ABCB11ABCC4CYP3A4SLCO1B3SLCO1B1 | |
| Erythromycin SCHEMBL11319270 | 0.92 | ABCB11 (1.00) | ABCB11ABCC4CYP3A4SLCO1B3SLCO1B1 | |
| Erythromycin SCHEMBL11319266 | 0.92 | ABCB11 (1.00) | ABCB11ABCC4CYP3A4SLCO1B3SLCO1B1 | |
| Erythromycin SCHEMBL284867 | 0.92 | CYP3A4 (0.95) | ABCB11ABCC4CYP3A4SLCO1B3SLCO1B1 | |
| Erythromycin SCHEMBL284866 | 0.92 | CYP3A4 (0.95) | ABCB11ABCC4CYP3A4SLCO1B3SLCO1B1 | |
| Erythromycin SCHEMBL9011892 | 0.91 | ABCB11 (0.87) | ABCB11ABCC4CYP3A4SLCO1B3SLCO1B1 | |
| Erythromycin SCHEMBL28498097 | 0.91 | ABCB11 (0.87) | ABCB11ABCC4CYP3A4SLCO1B3SLCO1B1 | |
| Erythromycin SCHEMBL9011755 | 0.91 | ABCB11 (0.87) | ABCB11ABCC4CYP3A4SLCO1B3SLCO1B1 | |
| Erythromycin SCHEMBL9011752 | 0.91 | ABCB11 (0.87) | ABCB11ABCC4CYP3A4SLCO1B3SLCO1B1 | |
| Erythromycin SCHEMBL28112678 | 0.91 | CYP3A4 (0.86) | ABCB11ABCC4CYP3A4SLCO1B3SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108786619-A | Bone material distributing equipment and method | 华沙整形外科股份有限公司 | 2018-11-13 | — | — | CN | disclosed |